Efficacy and safety of artemether in the treatment of chronic fascioliasis in Egypt: Exploratory phase-2 trials

PLoS Neglected Tropical Diseases

Volumn 5, Issue 9, 2011, Pages

  Keiser, Jennifer ^a,b   Sayed, Hanan ^c   El Ghanam, Maged ^c   Sabry, Hoda ^d   Anani, Saad ^e   El Wakeel, Aly ^f   Hatz, Christoph ^a,b,g   Utzinger, Jürg ^a,b   el Din, Sayed Seif ^d   El Maadawy, Walaa ^d   Botros, Sanaa ^d  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c El Nile St Warak Elhadar   (Egypt)

^d Giza   (Egypt)

^e MINISTRY OF HEALTH   (Egypt)

^f Ministry of Health and Population   (Egypt)

^g UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ARTEMETHER; ARTEMIDINE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; TRICLABENDAZOLE; UNCLASSIFIED DRUG; UREA; ANTHELMINTIC AGENT; ARTEMISININ DERIVATIVE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANALYTICAL PARAMETERS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CHILD; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CURE RATE; DIARRHEA; DIZZINESS; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG TREATMENT FAILURE; EGG REDUCTION RATE; EGYPT; ENZYME BLOOD LEVEL; EOSINOPHIL COUNT; FASCIOLIASIS; FATIGUE; FEMALE; FEVER; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFECTION RISK; INTERVENTION STUDY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NAUSEA; OPEN STUDY; OUTCOME ASSESSMENT; PHASE 2 CLINICAL TRIAL; PRESCHOOL CHILD; RISK REDUCTION; SCHOOL CHILD; SINGLE DRUG DOSE; TREATMENT DURATION; UREA BLOOD LEVEL; VOMITING; AGED; ANIMAL; CLINICAL TRIAL; DRUG EFFECT; FASCIOLA; FECES; ISOLATION AND PURIFICATION; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PARASITE IDENTIFICATION; PARASITOLOGY; PILOT STUDY; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; ANIMALS; ANTHELMINTICS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; EGYPT; FASCIOLA; FASCIOLIASIS; FECES; FEMALE; HUMANS; MALE; MIDDLE AGED; PARASITE EGG COUNT; PILOT PROJECTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80053438710     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001285     Document Type: Article

References (44)

1. Mas-Coma MS, Bargues MD, Valero MA, (2007) Plant-borne trematode zoonoses: fascioliasis and fasciolopsiais. In: Murrell KD, Fried B, editors. Food-Borne Parasitic Zoonoses New York Springer pp. 293-334.
2. Sithiathaworn P, Sripa B, Kaewkes S, Haswell-Elkins M, (2009) Food-borne trematodes. In: Cook GC, Zumla AI, editors. Manson's Tropical Diseases, 22nd edition London Saunders pp. 1461-1476.
3. Keiser J, Utzinger J, (2009) Food-borne trematodiases. Clin Microbiol Rev 22: 466-483.
4. Marcos LA, Terashima A, Gotuzzo E, (2008) Update on hepatobiliary flukes: fascioliasis, opisthorchiasis and clonorchiasis. Curr Opin Infect Dis 21: 523-530.
5. Esteban J-G, Gonzalez C, Curtale F, Muñoz-Antoli C, Valero MA, et al. (2003) Hyperendemic fascioliasis associated with schistosomiasis in villages in the Nile Delta of Egypt. Am J Trop Med Hyg 69: 429-437.
6. El-Shazly AM, El-Beshbishi SN, Azab MS, El-Malky M, Abdeltawab AH, et al. (2009) Past and present situation of human fascioliasis in Dakahlia Governorate, Egypt. J Egypt Soc Parasitol 39: 247-262.
7. Keiser J, Engels D, Büscher G, Utzinger J, (2005) Triclabendazole for the treatment of fascioliasis and paragonimiasis. Expert Opin Invest Drugs 14: 1513-1526.
8. Brennan GP, Fairweather I, Trudgett A, Hoey E, McCoy, et al. (2007) Understanding triclabendazole resistance. Exp Mol Pathol 82: 104-109.
9. Fairweather I, (2009) Triclabendazole progress report, 2005-2009: an advancement of learning? J Helminthol 83: 139-150.
10. McManus DP, Dalton JP, (2006) Vaccines against the zoonotic trematodes Schistosoma japonicum, Fasciola hepatica and Fasciola gigantica. Parasitology 133 (Suppl): S43-61.
11. White NJ, (2008) Qinghaosu (artemisinin): the price of success. Science 320: 330-334.
12. Utzinger J, Xiao SH, Tanner M, Keiser J, (2007) Artemisinins for schistosomiasis and beyond. Curr Opin Invest Drugs 8: 105-116.
13. Keiser J, Utzinger J, (2007) Food-borne trematodiasis: current chemotherapy and advances with artemisinins and synthetic trioxolanes. Trends Parasitol 23: 555-562.
14. Keiser J, Xiao SH, Tanner M, Utzinger J, (2006) Artesunate and artemether are effective fasciolicides in the rat model and in vitro. J Antimicrob Chemother 57: 1139-1145.
15. Duthaler U, Smith TA, Keiser J, (2010) In vivo and in vitro sensitivity of Fasciola hepatica to combinations of triclabendazole and artesunate, artemether or OZ78. Antimicrob Agents Chemother 54: 4596-4604.
16. Keiser J, Morson G, (2008) Fasciola hepatica: tegumental alterations in adult flukes following in vitro and in vivo administration of artesunate and artemether. Exp Parasitol 118: 228-237.
17. Shalaby HA, El Namaky AH, Kamel RO, (2009) In vitro effect of artemether and triclabendazole on adult Fasciola gigantica. Vet Parasitol 160: 76-82.
18. Keiser J, Rinaldi L, Veneziano V, Mezzino L, Tanner M, et al. (2008) Efficacy and safety of artemether against a natural Fasciola hepatica infection in sheep. Parasitol Res 103: 517-522.
19. Keiser J, Veneziano V, Rinaldi L, Mezzino L, Duthaler U, et al. (2009) Anthelmintic activity of artesunate against Fasciola hepatica in naturally infected sheep. Res Vet Sci 88: 107-110.
20. Hien TT, Truong NT, Minh NH, Dat HD, Dung NT, et al. (2008) A randomized controlled pilot study of artesunate versus triclabendazole for human fascioliasis in Central Vietnam. Am J Trop Med Hyg 78: 388-392.
21. Nosten F, White NJ, (2007) Artemisinin-based combination treatment of falciparum malaria. Am J Trop Med Hyg 77: 181-192.
22. Nosten F, (1994) Artemisinin: large community studies. Trans R Soc Trop Med Hyg 88 (Suppl 1): S45-46.
23. Julious S, (2005) Sample size of 12 per group rule of thumb for a pilot study. Pharm Stat 4: 287-291.
24. WHO (1995) Control of foodborne trematode infections. Report of a WHO study group. WHO Tech Rep Ser 849: 1-157.
25. Katz N, Chaves A, Pellegrino J, (1972) A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni. Rev Inst Med Trop São Paulo 14: 397-400.
26. Sapero JJ, Lawless DK, (1953) The MIF stain-preservation technic for the identification of intestinal protozoa. Am J Trop Med Hyg 2: 613-619.
27. Bergquist R, Johansen MV, Utzinger J, (2009) Diagnostic dilemmas in helminthology: what tools to use and when? Trends Parasitol 25: 151-156.
28. Curtale F, El-Wahab Hassanein YA, El Wakeel A, Mas-Coma S, Montresor A, (2003) Distribution of human fascioliasis by age and gender among rural population in the Nile Delta, Egypt. J Trop Pediatr 49: 264-268.
29. Mahmoud MR, Botros SS, (2005) Artemether as adjuvant therapy to praziquantel in murine Egyptian schistosomiasis mansoni. J Parasitol 91: 175-178.
30. Curtale F, Hammoud ES, El Wakeel A, Mas-Coma MS, Savioli L, (2001) Human fascioliasis, an emerging public health problem in the Nile Delta. Res Rev Parasitol 60: 129-134.
31. Keiser J, Duthaler U, Utzinger J, (2010) Update on the diagnosis and treatment of food-borne trematode infections. Curr Opin Infect Dis 23: 513-520.
32. Medhi B, Patyar S, Rao RS, Byrav DSP, Prakash A, (2009) Pharmacokinetic and toxicological profile of artemisinin compounds: an update. Pharmacology 84: 323-332.
33. Obonyo CO, Muok EM, Mwinzi PN, (2010) Efficacy of artesunate with sulfalene plus pyrimethamine versus praziquantel for treatment of Schistosoma mansoni in Kenyan children: an open-label randomised controlled trial. Lancet Infect Dis 10: 603-611.
34. De Clercq D, Vercruysse J, Verlé P, Niasse F, Kongs A, et al. (2000) Efficacy of artesunate against Schistosoma mansoni infections in Richard Toll, Senegal. Trans R Soc Trop Med Hyg 94: 90-91.
35. Borrmann S, Szlezák N, Faucher J-F, Matsiegui P-B, Neubauer R, et al. (2001) Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study. J Infect Dis 184: 1363-1366.
36. Keiser J, N'Guessan NA, Adoubryn KD, Silué KD, Vounatsou P, et al. (2010) Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial. Clin Infect Dis 50: 1205-1213.
37. Inyang-Etoh PC, Ejezie GC, Useh MF, Inyang Etoh EC, (2004) Efficacy of artesunate in the treatment of urinary schistosomiasis in an endemic community in Nigeria. Ann Trop Med Parasitol 98: 491-499.
38. Utzinger J, Tanner M, Keiser J, (2010) ACTs for schistosomiasis: do they act? Lancet Infect Dis 10: 579-581.
39. Sissoko MS, Dabo A, Traoré H, Diallo M, Traoré B, et al. (2009) Efficacy of artesunate + sulfamethoxypyrazine/pyrimethamine versus praziquantel in the treatment of Schistosoma haematobium in children. PLoS One 4: e6732.
40. Keiser J, Utzinger J, (2010) The drugs we have and the drugs we need against major helminth infections. Adv Parasitol 73: 197-230.
41. Barduagni P, Hassanein Y, Mohamed M, El Wakeel A, El Sayed M, et al. (2008) Use of triclabendazole for treatment of patients co-infected by Fasciola spp. and S. mansoni in Behera Governorate, Egypt. Parasitol Res 102: 631-633.
42. Zhao Q, Vargas M, Dong Y, Zhou L, Wang X, et al. (2010) Structure-activity relationship of an ozonide carboxylic acid (OZ78) against Fasciola hepatica. J Med Chem 53: 4223-4233.
43. White N, (1999) Antimalarial drug resistance and combination chemotherapy. Philos Trans R Soc Lond B Biol Sci 354: 739-749.
44. Ghavami G, Kazemali MR, Sardari S, (2010) Informatics of drug synergism in naturally occurring anticancer agents. Recent Pat Anticancer Drug Discov 6: 26-44.